Muna Bhanji, Director: Intellia Therapeutics NTLA Sell · Filed 25/05/01

Trade details

Type: Insider sale
Amount: $2,252.5
Shares · price: 265 sh · $8.50 a share
Held after: 19,203 sh
Stock: Intellia Therapeutics NTLA
Person: Muna BhanjiDirector
Trade date: 25/04/29
Filed: 25/05/01
Days to filing: 2 days

Sold 1.4% of holdings

Share of holding sold: 1.4%

Intellia Therapeutics trades, last 26 weeks

What else happened in Intellia Therapeutics around then

Filed or reported within 30 days of the trade day · 25/03/30~25/05/29

Muna Bhanji's recent trades

Muna BhanjiDirector
Planned sale10b5-1 planVeracyte
Planned sale10b5-1 plan
Veracyte
VCYT
$161K
3,728 sh
$161K
Filed 09/01
Traded 09/01
Muna BhanjiDirector
Sell10b5-1 planVeracyte
Sell10b5-1 plan
Veracyte
VCYT
$122.4K
4,589 sh
$122.4K
Filed 25/06/17
Traded 25/06/13
Muna BhanjiDirector
Planned sale10b5-1 planVeracyte
Planned sale10b5-1 plan
Veracyte
VCYT
$122.5K
4,589 sh
$122.5K
Filed 25/06/13
Traded 25/06/13
Muna BhanjiDirector
Sell10b5-1 planCytokinetics
Sell10b5-1 plan
Cytokinetics
CYTK
$43.2K
1,454 sh
$43.2K
Filed 25/05/15
Traded 25/05/15
Muna BhanjiDirector
Planned sale10b5-1 planCytokinetics
Planned sale10b5-1 plan
Cytokinetics
CYTK
$43.6K
1,454 sh
$43.6K
Filed 25/05/15
Traded 25/05/15